U.S./Canada/Israel: A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD

New Resource: Psychedelics Drug Development Tracker

U.S./Canada/Israel: A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD

MAPS Public Benefit Corporation

Posted 6 months ago

We are seeking volunteers for a research study who are at least 18 years old and have been diagnosed with PTSD. You must be in good physical health to participate.

Learn more: mdmaptsd.org
Learn more: clinicaltrials.gov
Learn more: Dear Doctor Letter

Apply Here

Job Features

Job Category

Clinical Trial

Click the button above to apply

Psilocybin Alpha

The definitive resource for investors in the emergent psychedelic medicine sector. Cut through the shroom stock noise with exclusive news, interviews, data and private financing opportunities.

Quick Links

Psychedelic Stocks and Companies
News & Interviews
Psychedelic Sector Jobs
Data Bank

Industry insights and interviews delivered to your inbox. No spam, just valuable information.

Psychedelic Sector Overview

Explore the Psychedelic Sector Landscape visually using our new tool.

Psychedelics Patent Trackers

We track the latest patents and filings related to psilocybin, MDMA and DMT.

Psychedelics Drug Development Tracker

From drug discovery to regulatory approval, we map drug development in psychedelics.

How to Buy Psychedelic Stocks

Looking to invest in psychedelics? This handy guide explains how to buy stocks and shares outside of Canada.

U.S./Canada/Israel: A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD

MAPS Public Benefit Corporation

Job Features

Job Category

Psilocybin Alpha

Quick Links

Newsletter

Join Our Newsletter

Psychedelic sector insights, interviews and analysis delivered to your inbox.

No thanks, continue to site.